This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 May;9(5):266-7.

doi: 10.1016/S1473-3099(09)70106-9.

H5N1 influenza vaccination policy in Japan

Michiaki Masuda, Shigeo Sugita, Kazumichi Kuroda, Hidekazu Nishimura

PMID: 19393952
DOI: 10.1016/S1473-3099(09)70106-9

H5N1 influenza vaccination policy in Japan

Michiaki Masuda et al. Lancet Infect Dis. 2009 May.

. 2009 May;9(5):266-7.

doi: 10.1016/S1473-3099(09)70106-9.

Authors

Michiaki Masuda, Shigeo Sugita, Kazumichi Kuroda, Hidekazu Nishimura

PMID: 19393952
DOI: 10.1016/S1473-3099(09)70106-9

No abstract available

PubMed Disclaimer

Similar articles

Pre- or post-pandemic influenza vaccine?
Osterhaus AD. Osterhaus AD. Vaccine. 2007 Jun 28;25(27):4983-4. doi: 10.1016/j.vaccine.2007.05.033. Epub 2007 May 29. Vaccine. 2007. PMID: 17555851 No abstract available.
Medical countermeasures for pandemic influenza: ethics and the law.
Gostin LO. Gostin LO. JAMA. 2006 Feb 1;295(5):554-6. doi: 10.1001/jama.295.5.554. JAMA. 2006. PMID: 16449621 No abstract available.
Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic.
Qin CF, Qin ED. Qin CF, et al. Chin Med J (Engl). 2008 Aug 5;121(15):1481-3. Chin Med J (Engl). 2008. PMID: 18959131 No abstract available.
Clinical evaluation of vaccines for pandemic influenza H5N1.
Pareek M, Stephenson I. Pareek M, et al. Br J Hosp Med (Lond). 2007 Feb;68(2):80-4. doi: 10.12968/hmed.2007.68.2.22826. Br J Hosp Med (Lond). 2007. PMID: 17370705 Review.
Strategies for developing vaccines against H5N1 influenza A viruses.
Horimoto T, Kawaoka Y. Horimoto T, et al. Trends Mol Med. 2006 Nov;12(11):506-14. doi: 10.1016/j.molmed.2006.09.003. Epub 2006 Sep 29. Trends Mol Med. 2006. PMID: 17011235 Review.

See all similar articles

Cited by

Telephone monitoring of adverse events during an MF59®-adjuvanted H5N1 influenza vaccination campaign in Taiwan.
Huang WT, Chang CH, Peng MC. Huang WT, et al. Hum Vaccin Immunother. 2014;10(1):100-3. doi: 10.4161/hv.26737. Epub 2013 Oct 8. Hum Vaccin Immunother. 2014. PMID: 24104613 Free PMC article.
Comprehensive Analysis of Antibodies Induced by Vaccination with 4 Kinds of Avian Influenza H5N1 Pre-Pandemic Vaccines.
Ohshima N, Iba Y, Kubota-Koketsu R, Yamasaki A, Majima K, Kurosawa G, Hirano D, Yoshida S, Sugiura M, Asano Y, Okuno Y, Kurosawa Y. Ohshima N, et al. Int J Mol Sci. 2020 Oct 8;21(19):7422. doi: 10.3390/ijms21197422. Int J Mol Sci. 2020. PMID: 33050014 Free PMC article.
A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults.
Nagai H, Ikematsu H, Tenjinbaru K, Maeda A, Dramé M, Roman FP. Nagai H, et al. BMC Infect Dis. 2010 Nov 25;10:338. doi: 10.1186/1471-2334-10-338. BMC Infect Dis. 2010. PMID: 21108818 Free PMC article. Clinical Trial.
A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.
Samaan G, McPherson M, Partridge J. Samaan G, et al. PLoS One. 2013 Jul 16;8(7):e70003. doi: 10.1371/journal.pone.0070003. Print 2013. PLoS One. 2013. PMID: 23875015 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information